Hypotensive Response to Losartan in Normal Rats: Role of Ang II and the Area Postrema

Hypertension

Volumn 27, Issue 3 II, 1996, Pages 598-606

  Collister, John P ^a   Hornfeldt, Barbara J ^a   Osborn, John W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Blood pressure; Losartan; Receptors, angiotensin type 1; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; LOSARTAN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA POSTREMA; BLOOD PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; HISTOLOGY; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; BLOOD PRESSURE; CEREBRAL VENTRICLES; HYPOTENSION; IMIDAZOLES; LOSARTAN; MALE; RATS; RATS, SPRAGUE-DAWLEY; TETRAZOLES;

EID: 0029867239     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.27.3.598     Document Type: Article

References (51)

1. Brown AJ, Casals-Stenzel J, Gifford J, Lever AF, Morten JJ. Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am J Physiol. 1981;241:H381-H388.
2. Krieger JE, Cowley AW Jr. Prevention of salt angiotensin II hypertension by servo control of body water. Am J Physiol. 1990;258: H994-H1002.
3. Hall JE. Control of sodium excretion by angiotensin II: intrarenal mechanism and blood pressure regulation. Am J Physiol. 1986;250: R960-R972.
4. Cowley AW Jr, Krieger JE. Role of fluid volume retention in angiotensin II salt-dependent hypertension. Acta Physiol Scand. 1990;139(suppl 591):100-106.
5. Reid IA. Interactions between Ang II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol. 1992;262:E763-E778.
6. Griffin SA, Brown WCB, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany M, Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 1991;17:626-635.
7. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:205-251.
8. Sweet CS, Blaine EH. Angiotensin converting enzyme inhibitors. In: van Zwieten PA, ed. Handbook of Hypertension, Volume 3: Pharmacology of Antihypertensive Drugs. Amsterdam, Netherlands: Elsevier Science Publishing; 1984:343-363.
9. Matsukawa T, Mano T, Gotoh E, Ishii M. Elevated sympathetic nerve activity in patients with accelerated essential hypertension. J Clin Invest. 1993;92:25-28.
10. Bunkenburg B, Schnell C, Baum H-P, Cumin F, Wood JM. Prolonged angiotensin II antagonism in spontaneously hypertensive rats: hemodynamic and biochemical consequences. Hypertension. 1991;18:278-288.
11. 1 receptor blockade in sodium-replete rats. FASEB J. 1994; 8:A579. Abstract.
12. Bickerton RK, Buckley JP. Evidence for a central mechanism in angiotensin induced hypertension. Proc Soc Exp Biol Med. 1961; 106:834-836.
13. Yu R, Dickinson CJ. Neurogenic effects of angiotensin. Lancet. 1965;2:1276-1277.
14. Pawloski CM, Kanagy NL, Fink GD. Contribution of increased neurogenic vascular tone to angiotensin II-induced hypertension. FASEB J. 1989;3:A551. Abstract.
15. Gorbea-Oppliger VJ, Fink GD. Clonidine reverses the slowly developing hypertension produced by low doses of angiotensin II. Hypertension. 1994;23:844-847.
16. Luft FC, Wilcox CS, Unger T, Kuhn R, Demmert G, Rohmeiss P, Ganten D, Sterzel RB. Angiotensin-induced hypertension in the rat: sympathetic nerve activity and prostaglandins. Hypertension. 1989;14:396-403.
17. Smits GJ, Koepke JP, Blaine EH. Reversal of low dose angiotensin hypertension by angiotensin receptor antagonists. Hypertension. 1991;18:17-21.
18. Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J. 1993;7:678-686.
19. Fink GD, Bruner CA, Mangiapane ML. Area postrema is critical for angiotensin-induced hypertension in rats. Hypertension. 1987;9: 355-361.
20. Edwards GL, Beltz TG, Power JD, Johnson AK. Rapid-onset "need-free" sodium appetite after lesions of the dorsomedial medulla. Am J Physiol. 1993;264:R1242-R1247.
21. Osborn JW, England SK. Normalization of arterial pressure after barodenervation: role of pressure natriuresis. Am J Physiol. 1990; 259:R1172-R1180.
22. Osborn JW, Provo BJ, Montana JS III, Trostel KA. Salt-sensitive hypertension caused by long-term a-adrenergic blockade in the rat. Hypertension. 1993;21:995-999.
23. Neter J, Wasserman W. Applied Linear Statistical Models. Homewood, Ill: Richard D Irwin, Inc; 1974.
24. Osborn JW, Provo BJ. Salt-dependent hypertension in the sinoaortic denervated rat. Hypertension. 1992;19:658-662.
25. Skoog KM, Mangiapane ML. Area postrema and cardiovascular regulation in rats. Am J Physiol. 1988;254:H963-H969.
26. Tsunoda K, Abe K, Hagino T, Omata K, Misawa S, Imai Y, Yoshinaga K. Hypotensive effect of losartan, a nonpeptide angiotensin II receptor antagonist, in essential hypertension. Am J Hypertens. 1993;6:28-32.
27. Berecek KH, Kirk KA, Nagahama S, Oparil S. Sympathetic function in spontaneously hypertensive rats after chronic administration of captopril. Am J Physiol. 1987;252:H796-H806.
28. Cheng SWT, Kirk KA, Robertson JD, Berecek KH. Brain angiotensin II and baroreceptor reflex function in spontaneously hypertensive rats. Hypertension. 1989;14:274-281.
29. Lever AF. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J Hypertens. 1986;4:515-524.
30. Melaragno MG, Fink GD. Enhanced slow pressor effect of angiotensin II in two kidney, one clip rats. Hypertension. 1995;25:288-293.
31. Bengis RG, Coleman TG, Young DB, McCaa RE. Long-term blockade of angiotensin formation in various normotensive and hypertensive rat models using converting enzyme inhibitor (SQ 14,225). Circ Res. 1978;43(suppl I):I-45-I-53.
32. Mento PF, Wilkes BM. Plasma angiotensins and blood pressure during converting enzyme inhibition. Hypertension. 1987;9(suppl III):III-42-III-48.
33. MacGregor GA, Markandu ND, Bayliss J, Roulston JE, Squires M, Morton JJ. Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects. Br Med J. 1981;283:401-403.
34. MacGregor GA, Markandu ND, Roulston JE, Jones JC. Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature. 1981;291:329-331.
35. Gorbea-Oppliger VJ, Melaragno MG, Potter GS, Petit RL, Fink GD. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects. J Pharmacol Exp Ther. 1994;271:804-810.
36. McCubbin JW, DeMoura RS, Page IH, Olmsted F. Arterial hypertension elicited by subpressor amounts of angiotensin. Science. 1965;149:1394-1395.
37. Yu R, Dickinson CJ. The progressive pressor response to angiotensin in the rabbit: the role of the sympathetic nervous system. Arch Int Pharmacodyn Ther. 1971;191:24-36.
38. Dickinson CJ, Lawrence JR. A slowly developing pressor response to small concentrations of angiotensin: its bearing on the pathogenesis of chronic renal hypertension. Lancet. 1963;1:1354-1356.
39. Lever AF. The renin-angiotensin system. In: Robertson JIS, Nicholls M, eds. Biochemistry, Physiology, Pathophysiology and Therapeutics. New York, NY: Gower Medical Publishing, Raven Press, Ltd; 1993:28.1-28.9.
40. 1 angiotensin receptors in rat brain, kidney and adrenals demonstrated by in vivo autoradiography. Clin Exp Pharmacol Physiol. 1994;21:557-567.
41. Lowes VL, McLean LE, Kasting NW, Ferguson AV. Cardiovascular consequences of microinjection of vasopressin and angiotensin II in the area postrema. Am J Physiol. 1993;265:R625-R631.
42. Gorbea-Oppliger VJ, Fink GD. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II. J Pharmacol Exp Ther. 1995; 273:611-616.
43. Ferrario CM. Neurogenic actions of angiotensin II. Hypertension. 1983;5(suppl V):V-73-V-79.
44. Reid IA. Interactions between Ang II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol. 1992;262:E763-E778.
45. Brooks VL, Osborn JW. Hormonal-sympathetic interactions in long-term regulation of arterial pressure: an hypothesis. Am J Physiol. 1995;268:R1343-R1358.
46. Wood JM, Schnell CR, Levens NR. Kidney is an important target for the antihypertensive action of an angiotensin II receptor antagonist in spontaneously hypertensive rats. Hypertension. 1993;21: 1056-1061.
47. Guyton AC, Coleman TG, Cowley AW Jr, Manning RD Jr, Norman RA Jr, Ferguson JD. A systems analysis approach to understanding long-range arterial blood pressure control and hypertension. Circ Res. 1974;35:159-176.
48. Cowley AW Jr. Long-term control of arterial pressure. Physiol Rev. 1992;72:231-300.
49. Li Z, Bains JS, Ferguson AV. Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat. Brain Res Bull. 1993;30:33-39.
50. Munzenmaier DH, Greene AS. Angiotensin II receptor subtypes mediate opposing actions in the control of blood pressure and vascular tone. Hypertension. 1995;26:579. Abstract.
51. Skoog KM, Blair ML, Sladek CD, Williams WM, Mangiapane ML. Area postrema: essential for support of arterial pressure after hemorrhage in rats. Am J Physiol. 1990;258:R1472-R1478.